# Ability of a Molecule (Prima) to Restore Physiological Differentiation in Epithelium Expressing Gene p63

> **NCT02896387** · — · TERMINATED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 5 (actual)

## Conditions studied

- Ectodermal Dysplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02896387
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-03-03
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Laboratory change, stem cell circuit stopped
- **Last updated:** 2022-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896387, "Ability of a Molecule (Prima) to Restore Physiological Differentiation in Epithelium Expressing Gene p63". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02896387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*